Consun Pharmaceutical (01681) Announces Monthly Equity Movements for February 2026
Bulletin Express
Yesterday
Consun Pharmaceutical Group Limited (01681) reported no changes in its authorized share capital for February 2026, remaining at 5,000,000,000 ordinary shares at HKD 0.1 par value each, with total authorized share capital at HKD 500.00 million.
At the end of February 2026, the total issued shares (excluding treasury shares) decreased from 841,508,111 to 841,423,111, reflecting a net decrease of 85,000. This net change comprised 15,000 shares newly issued under a share option exercise and a redemption of 100,000 shares. The share option exercise contributed HKD 60,150.00 in proceeds. The issuer confirmed that the public float requirement of 25% continues to be met.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.